Multidisciplinary treatment including repeated surgical excisions and interleukin-2 may help prolong survival in patients with highly aggressive primary breast angiosarcoma.
May support IL-2-inclusive multidisciplinary care in aggressive breast angiosarcoma; hypothesis-generating and requires prospective validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hokimoto et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: